A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial
Conclusions:
At 6 months, fractionated CO2 vaginal laser and vaginal estrogen treatment resulted in similar improvement in genitourinary syndrome of menopause symptoms as well as urinary and sexual function. Overall, 70% to 80% of participants were satisfied or very satisfied with either treatment and there were no serious adverse events.
Video Summary:http://links.lww.com/MENO/A470.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
More News: Cancer & Oncology | Clinical Trials | Laser Surgery | Laser Therapy | Men | Menopause | OBGYN | Statistics | Study | Women